Evidence map›Paper›PMID 32919101›Full record

ArticleEBioMedicine2020

Lipid laden macrophages and electronic cigarettes in healthy adults.

Peter G Shields, Min-Ae Song, Jo L Freudenheim, Theodore M Brasky, Joseph P McElroy, Sarah A Reisinger, Daniel Y Weng, Rongqin Ren, Thomas Eissenberg, Mark D Wewers and 1 more

Open access · goldAbstract read
In one paragraph

Article in EBioMedicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Article
  8. CYP1B1 Mediates Cigarette Smoke-Induced Lipid Accumulation in Alveolar Type 2 Cells.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  9. Linking Lipid Metabolism and Immune Function: New Insights into Chronic Respiratory Diseases.Pathophysiology : the official journal of the International Society for Pathophysiology · 2025
    Review
  10. Review
  11. Review
  12. Article
  13. E-cigs put the squeeze on macrophages.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  14. Alveolar macrophage function is impaired following inhalation of berry e-cigarette vapor.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Peter G ShieldsComprehensive Cancer Center, The Ohio State University and James Cancer Hospital, 460W. 10th Avenue, 9th Floor, Suite D920, Columbus, OH 43210-1240, United States. Electronic address: Peter.Shields@osumc.edu.
Min-Ae SongDivision of Environmental Health Science, College of Public Health, The Ohio State University, Columbus, United States.
Jo L FreudenheimDepartment of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY, United States.
Theodore M BraskyComprehensive Cancer Center, The Ohio State University and James Cancer Hospital, 460W. 10th Avenue, 9th Floor, Suite D920, Columbus, OH 43210-1240, United States.
Joseph P McElroyCenter for Biostatistics, Department of Biomedical Informatics, The Ohio State University, Columbus, OH, United States.
Sarah A ReisingerComprehensive Cancer Center, The Ohio State University and James Cancer Hospital, 460W. 10th Avenue, 9th Floor, Suite D920, Columbus, OH 43210-1240, United States.
Daniel Y WengComprehensive Cancer Center, The Ohio State University and James Cancer Hospital, 460W. 10th Avenue, 9th Floor, Suite D920, Columbus, OH 43210-1240, United States.
Rongqin RenDepartment of Pathology, Ohio State University Wexner Medical Center, Columbus, OH, United States.
Thomas EissenbergCenter for the Study of Tobacco Products, Department of Psychology, Virginia Commonwealth University, Richmond, VA, United States.
Mark D WewersPulmonary and Critical Care Medicine, Department of Internal Medicine, The Ohio State University, Columbus, OH, United States.
Konstantin ShiloDepartment of Pathology, Ohio State University Wexner Medical Center, Columbus, OH, United States.
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute · USThe Ohio State University · USThe Ohio State University Wexner Medical Center · USUniversity at Buffalo, State University of New York · USVirginia Commonwealth University · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Jennifer A. Woyach · 1985 to 2026
$132.3M
NCI NIH HHS P30 CA016058
6 · The paper itself

Abstract

backgroundAn outbreak of E-cigarette or Vaping Product Use-Associated Lung Injury (EVALI) with significant morbidity and mortality was reported in 2019. While most patients with EVALI report vaping tetrahydrocannabinol (THC) oils contaminated with vitamin E acetate, a subset report only vaping with nicotine-containing electronic cigarettes (e-cigs). Whether or not e-cigs cause EVALI, the outbreak highlights the need for identifying long term health effects of e-cigs. EVALI pathology includes alveolar damage, pneumonitis and/or organizing pneumonia, often with lipid-laden macrophages (LLM). We assessed LLM in the lungs of healthy smokers, e-cig users, and never-smokers as a potential marker of e-cig toxicity and EVALI.

methodsA cross-sectional study using bronchoscopy was conducted in healthy smokers, e-cig users, and never-smokers (n = 64). LLM, inflammatory cell counts, and cytokines were determined in bronchial alveolar fluids (BAL). E-cig users included both never-smokers and former light smokers.

findingsHigh LLM was found in the lungs of almost all smokers and half of the e-cig users, but not those of never-smokers. LLM were not related to THC exposure or smoking history. LLM were significantly associated with inflammatory cytokines IL-4 and IL-10 in e-cig users, but not smoking-related cytokines.

interpretationThis is the first report of lung LLM comparing apparently healthy smokers, e-cig users, and never-smokers. LLM are not a specific marker for EVALI given the frequent positivity in smokers; whether LLMs are a marker of lung inflammation in some e-cig users requires further study.

fundingThe National Cancer Institute, the National Heart, Lung, and Blood Institute, the Food and Drug Administration Center for Tobacco Products, the National Center For Advancing Translational Sciences, and Pelotonia Intramural Research Funds.

Indexed as

Electronic Nicotine Delivery SystemsAdultBiomarkersCross-Sectional StudiesCytokinesEnvironmental ExposureFemaleFoam CellsHealthy VolunteersHumansImmunohistochemistryInflammation MediatorsLung InjuryMaleNon-SmokersPublic Health SurveillanceBiomarkersCytokinesInflammation MediatorsBronchoscopyCytokinesEVALINicotineVaping

Identifiers

PMID32919101
PMCPMC7494450
OpenAlexW3083850631

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.